Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PFO Closure Products Lose “Humanitarian Device” Status

This article was originally published in The Gray Sheet

Executive Summary

NMT Medical has a step up on patent foramen ovale closure competitor AGA Medical after both firms got word from FDA that they should remove their limited-release stroke treatments from the U.S. market

You may also be interested in...



Gore Nabs PFO-Closure Approval For Stroke

WL Gore's Cardioform Septal Occluder is now the second device to gain PMA approval to close the patent foramen ovale heart defect, to help prevent repeat ischemic stroke, according to FDA's website.

AGA Medical Pursues Stroke, Migraine Indications And $200 Mil. IPO

AGA Medical hopes to complete a pivotal U.S. trial by year-end assessing its Amplatzer PFO Occluder for prevention of recurrent cryptogenic strokes, the company says in a June 20 prospectus for a planned initial public offering worth up to $200 million

AGA Medical Pursues Stroke, Migraine Indications And $200 Mil. IPO

AGA Medical hopes to complete a pivotal U.S. trial by year-end assessing its Amplatzer PFO Occluder for prevention of recurrent cryptogenic strokes, the company says in a June 20 prospectus for a planned initial public offering worth up to $200 million

Related Content

UsernamePublicRestriction

Register

MT023904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel